KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Receivables (2016 - 2025)

Historic Receivables for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $408.1 million.

  • Evolent Health's Receivables fell 61.26% to $408.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.1 million, marking a year-over-year decrease of 61.26%. This contributed to the annual value of $420.9 million for FY2024, which is 9991.09% down from last year.
  • Evolent Health's Receivables amounted to $408.1 million in Q3 2025, which was down 61.26% from $359.8 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Receivables registered a high of $472.4 billion during Q4 2023, and its lowest value of $127.7 million during Q2 2022.
  • Its 5-year average for Receivables is $25.2 billion, with a median of $359.8 million in 2025.
  • In the last 5 years, Evolent Health's Receivables surged by 17542954.29% in 2023 and then tumbled by 9991.09% in 2024.
  • Over the past 5 years, Evolent Health's Receivables (Quarter) stood at $171.5 million in 2021, then soared by 56.91% to $269.1 million in 2022, then soared by 175429.54% to $472.4 billion in 2023, then tumbled by 99.91% to $420.9 million in 2024, then dropped by 3.06% to $408.1 million in 2025.
  • Its Receivables was $408.1 million in Q3 2025, compared to $359.8 million in Q2 2025 and $440.8 million in Q1 2025.